Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade GliomaPhase I Study of Methylfolate in Recurrent High-Grade Glioma

Overview of attention for article published in Cancer Research Communications, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 396)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 4 posts from 4 blogs.

It was January, 2020, the very beginning of COVID, when news articles began appearing that connected the genetics of the virus…

Below, we have summarised the latest news and research in the genomics space from the past week. Top stories from the past…

by Tom…

A folic acid-like drug, L-methylfolate, when administered alongside the standard therapy for patients with recurrent…